Thus, the possible post-COVID-19 cognitive decline and the relationship between the APOE polymorphism and post-COVID-19 severe and cognitive conditions raise concerns regarding the subsequent development of neurodegenerative diseases, such as Alzheimer’s disease [12]. The gene discussed is APOE; the disease is neurodegenerative disease.